Jazz Pharmaceuticals (JAZZ) Net Income towards Common Stockholders (QoQ) (2010 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Jazz Pharmaceuticals | 14.35 Bn | 12.51 Bn | 934.80 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 44.05% |
| Dec 31, 2025 | -19.08% |
| Sep 30, 2025 | 135.00% |
| Jun 30, 2025 | -680.82% |
| Mar 31, 2025 | -148.13% |
| Dec 31, 2024 | -11.24% |
| Sep 30, 2024 | 27.74% |
| Jun 30, 2024 | 1,367.33% |
| Mar 31, 2024 | -114.06% |
| Dec 31, 2023 | -35.50% |
| Sep 30, 2023 | 38.30% |
| Jun 30, 2023 | 50.63% |
| Mar 31, 2023 | 129.35% |
| Dec 31, 2022 | -1,300.76% |
| Sep 30, 2022 | -146.14% |
| Jun 30, 2022 | 537.36% |
| Mar 31, 2022 | 118.01% |
| Dec 31, 2021 | 34.75% |
| Sep 30, 2021 | 86.40% |
| Jun 30, 2021 | -409.86% |
| Mar 31, 2021 | -12.20% |
| Dec 31, 2020 | -9.96% |
| Sep 30, 2020 | 27.61% |
| Jun 30, 2020 | 173.83% |
| Mar 31, 2020 | -309.86% |
| Dec 31, 2019 | -27.12% |
| Sep 30, 2019 | -60.69% |
| Jun 30, 2019 | 205.15% |
| Mar 31, 2019 | -46.29% |
| Dec 31, 2018 | 7.02% |
| Sep 30, 2018 | 61.24% |
| Jun 30, 2018 | 100.54% |
| Mar 31, 2018 | -80.08% |
| Dec 31, 2017 | 264.55% |
| Sep 30, 2017 | -39.70% |
| Jun 30, 2017 | 22.08% |
| Mar 31, 2017 | -25.90% |
| Dec 31, 2016 | 30.06% |
| Sep 30, 2016 | -21.46% |
| Jun 30, 2016 | 51.03% |
| Mar 31, 2016 | -8.40% |
| Dec 31, 2015 | -5.91% |
| Sep 30, 2015 | -0.17% |
| Jun 30, 2015 | 24.63% |
| Mar 31, 2015 | -13.37% |
| Dec 31, 2014 | 216.71% |
| Sep 30, 2014 | -40.88% |
| Jun 30, 2014 | 146.55% |
| Dec 31, 2012 | 8,997.67% |
| Sep 30, 2012 | 90.27% |
| Jun 30, 2012 | -55.36% |
| Jun 30, 2011 | 52.11% |
| Mar 31, 2011 | 63.16% |
| Dec 31, 2010 | 1.02% |
| Sep 30, 2010 | 28.19% |